Explained herein are pharmaceutical packaging devices which reduce oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive drugs, such programs which includes a syringe with an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with really very low permeability to oxygen and comprises